Core Viewpoint - The company plans to provide guarantees totaling up to RMB 7 billion for its subsidiaries, which is a significant portion of its net assets, raising concerns about financial risk and leverage [2][3][9]. Summary by Sections 1. Overview of External Guarantees - The company intends to apply for a total comprehensive credit limit of up to RMB 15 billion from banks and financial institutions from the 2024 annual general meeting until the 2025 annual general meeting, with RMB 4 billion pending approval from a subsequent extraordinary general meeting [3]. - The expected guarantees for subsidiaries will not exceed RMB 7 billion, with RMB 6.5 billion allocated for subsidiaries with an asset-liability ratio above 70% and RMB 500 million for those below [3][4]. 2. Expected Guarantee Amounts - As of September 30, 2025, the company has provided guarantees amounting to RMB 5.525 billion to its subsidiaries, based on signed guarantee contracts [5]. - The guarantee amount for Fujian Del Medical Industry Co., Ltd. is RMB 1.75 billion, which includes a portion allocated for supply chain financing [8]. 3. Board of Directors' Opinion - The board believes that providing guarantees for subsidiaries is based on a comprehensive analysis of their profitability, debt repayment ability, and overall risk, and is aligned with the company's operational funding needs [9]. - The total approved guarantee amount of RMB 7 billion represents 472.58% of the company's latest audited net assets attributable to shareholders [9]. 4. Cumulative External Guarantees - The total guarantee amount of RMB 5.525 billion accounts for 373.02% of the company's latest audited net assets, while the actual guarantee balance is RMB 2.46 billion, representing 166.08% [9]. - The company has not provided guarantees to external entities and has no overdue guarantees or related litigation [9].
上海建发致新医疗科技集团股份有限公司关于公司2025年度对外担保额度预计的公告